Atezolizumab
ATC L01FF05 · 12 markets · 48 records
AU 8 records · 6 shown of 6
Only this ingredient
- 1,200 mg/20 mLinjectionTECENTRIQ
- 840 mg/14 mLinjectionTECENTRIQ
- 1,875 mg/15 mLinjectionTECENTRIQ SC
- 1,875 mginjectionTECENTRIQ SC atezolizumab 1875 mg/15 mL solution for injection vial
- 1,200 mginjectionTECENTRIQ atezolizumab (rch) 1200 mg/20 mL injection concentrated vial
- 840 mginjectionTECENTRIQ atezolizumab (rch) 1200 mg/20 mL injection concentrated vial
2 records · 0 manufacturers 2 registros · 0 fabricantes 2 个记录 · 0 个厂家 2 個記錄 · 0 個廠商
Full list in the data package Lista completa en el paquete de datos 完整清单见数据包 完整清單見資料包
ES 8 records · 3 shown of 3
GB 7 records · 4 shown of 4
Only this ingredient
- 1,200 mg/20 mLinjectionTecentriq 1200mg/20ml concentrate for solution for infusion vialsTecentriq 1200mg/20ml solution for infusion vials
- 840 mg/14 mLinjectionTecentriq 1200mg/20ml concentrate for solution for infusion vials
- 1,875 mg/15 mLinjectionTecentriq 1200mg/20ml solution for infusion vials
- 1,200 mg/250 mLinjectionManufacturer: Special Order
HK 4 records · 0 shown of 0
4 records · 0 manufacturers 4 registros · 0 fabricantes 4 个记录 · 0 个厂家 4 個記錄 · 0 個廠商
Full list in the data package Lista completa en el paquete de datos 完整清单见数据包 完整清單見資料包
US 3 records · 3 shown of 3
Combination products containing this ingredient
- 1,875 mg/15 mLinjection CombinationAtezolizumab 1,875 mg/15 mL + Hyaluronidase (Human Recombinant) 30,000 unit/15 mLTecentriq Hybreza
CA 3 records · 2 shown of 2
Only this ingredient
- 125 mgliquidTECENTRIQ SC
- 60 mg/1 mLliquidTECENTRIQ
SG 3 records · 3 shown of 3
Only this ingredient
- 840 mg/14 mLinjectionTECENTRIQ CONCENTRATE FOR SOLUTION FOR INFUSION 840MG/14ML
- 1,875 mg/15 mLinjectionTECENTRIQ SOLUTION FOR INJECTION 1875MG/15ML
- 1,200 mginjectionTECENTRIQ CONCENTRATE FOR SOLUTION FOR INFUSION 840MG/14ML
FR 3 records · 3 shown of 3
Only this ingredient
- 1,200 mg/20 mLinjectionTECENTRIQ 1200 mg, solution à diluer pour perfusion
- 840 mg/14 mLinjectionTECENTRIQ 1200 mg, solution à diluer pour perfusion
- 1,875 mginjectionTECENTRIQ 1 875 mg, solution injectable
TW 2 records · 0 shown of 0
2 records · 0 manufacturers 2 registros · 0 fabricantes 2 个记录 · 0 个厂家 2 個記錄 · 0 個廠商
Full list in the data package Lista completa en el paquete de datos 完整清单见数据包 完整清單見資料包
CN 1 records · 1 shown of 1
Only this ingredient
- 1,200 mg/20 mLinjection泰圣奇阿替利珠单抗
MX 1 records · 0 shown of 0
1 records · 0 manufacturers 1 registros · 0 fabricantes 1 个记录 · 0 个厂家 1 個記錄 · 0 個廠商
Full list in the data package Lista completa en el paquete de datos 完整清单见数据包 完整清單見資料包
EU 1 records · 0 shown of 0
EU centralised authorisation (EMA) — Authorised at EU level — not a record of sale in any single country. The EU register carries no strength, dosage form or pack size.
1 records · 0 manufacturers 1 registros · 0 fabricantes 1 个记录 · 0 个厂家 1 個記錄 · 0 個廠商
Full list in the data package Lista completa en el paquete de datos 完整清单见数据包 完整清單見資料包
| Strength / form / release | US | GB | CA | AU | SG | CN | ES | MX | TW | HK | EU | FR |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1,200 mg/20 mLRecorded as: 1.2 g/20 mL injection | TECENTRIQ | Tecentriq 1200mg/20ml concentrate for solution for infusion vials Tecentriq 1200mg/20ml solution for infusion vials | TECENTRIQ | 泰圣奇阿替利珠单抗 | TECENTRIQ 1200 mg, solution à diluer pour perfusion | |||||||
| 840 mg/14 mL injection | TECENTRIQ | Tecentriq 1200mg/20ml concentrate for solution for infusion vials | TECENTRIQ | TECENTRIQ CONCENTRATE FOR SOLUTION FOR INFUSION 840MG/14ML | TECENTRIQ 1200 mg, solution à diluer pour perfusion | |||||||
| 1,875 mg/15 mLRecorded as: 1.875 g/15 mL injection | Tecentriq 1200mg/20ml solution for infusion vials | TECENTRIQ SC | TECENTRIQ SOLUTION FOR INJECTION 1875MG/15ML | |||||||||
| 1,875 mg injection | TECENTRIQ SC atezolizumab 1875 mg/15 mL solution for injection vial | TECENTRIQ | TECENTRIQ 1 875 mg, solution injectable | |||||||||
| 1,200 mg injection | TECENTRIQ atezolizumab (rch) 1200 mg/20 mL injection concentrated vial | TECENTRIQ CONCENTRATE FOR SOLUTION FOR INFUSION 840MG/14ML | ||||||||||
| 840 mg injection | TECENTRIQ atezolizumab (rch) 1200 mg/20 mL injection concentrated vial | TECENTRIQ | ||||||||||
| 125 mg liquid | TECENTRIQ SC | |||||||||||
| 60 mg/1 mL liquid | TECENTRIQ | |||||||||||
| 1,200 mg/250 mLRecorded as: 1.2 g/250 mL injection | Manufacturer: Special Order | |||||||||||
| 60 mg/1 mL injection | TECENTRIQ | |||||||||||
| 1,875 mg/15 mL Combination Atezolizumab 1,875 mg/15 mL + Hyaluronidase (Human Recombinant) 30,000 unit/15 mL injection | Tecentriq Hybreza | |||||||||||
unknown | TECENTRIQ TECENTRIQ SC | TECENTRIQ CONCENTRATE FOR SOLUTION FOR INFUSION 840MG/14ML Tecentriq Solution for Subcutaneous Injection | TECENTRIQ | |||||||||
injection | TECENTRIQ Tecentriq Solution for Subcutaneous 癌自禦 注射劑+1癌自禦皮下注射劑 | |||||||||||
liquid | TECENTRIQ SC |
Scroll horizontally for more markets →
Each country column shows the locally registered trade names — not translations.
5 more strength/form rows are recorded only in CA · ES · MX · TW and are not shown in this table. Hay 5 filas de concentración/forma registradas solo en CA · ES · MX · TW que no se muestran en esta tabla. 另有 5 个规格/剂型仅在 CA · ES · MX · TW 有记录(未在本表显示)。 另有 5 個規格/劑型僅在 CA · ES · MX · TW 有記錄(未在本表顯示)。
“not disclosed” means the source does not publish the strength — it does not mean the product has none.
Hong Kong records are name/ingredient-level only: no strength, dosage form or registration status; on the register does not prove current supply.
Australia ARTG data has no registration-status column, so status is shown as unknown; being on the register does not mean currently marketed.
EU centralised authorisation (EMA) — Authorised at EU level — not a record of sale in any single country. The EU register carries no strength, dosage form or pack size.
Discontinued, withdrawn or unverified-status products are hidden by default; Hong Kong and Australia records are shown as exceptions.